Search Results - "Santos Rubio, M D"

Impact of a multidisciplinary medication reconciliation program on clinical outcomes: A pre-post intervention study in surgical patients by Guisado-Gil, A.B., Ramírez-Duque, N., Barón-Franco, B., Sánchez-Hidalgo, M., De la Portilla, F., Santos-Rubio, M.D.

“…Previous studies have evaluated the effects of medication reconciliation (MR) and suggest that it is effective in decreasing medication discrepancies…”
Get full text

Impact of medication reconciliation on health outcomes: An overview of systematic reviews by Guisado-Gil, A.B., Mejías-Trueba, M., Alfaro-Lara, E.R., Sánchez-Hidalgo, M., Ramírez-Duque, N., Santos-Rubio, M.D.

“…Recent systematic reviews and meta-analyses suggest that medication reconciliation (MR) is effective in decreasing the risk of medication discrepancies…”
Get full text

5PSQ-063 Persistence of tyrosine kinase inhibitors in advanced renal cell carcinoma by Guzman Ramos, MI, Barriga Rodríguez, P, Alvarado Fernández, MD, García Giménez, I, Santos Rubio, MD

“…Background and importanceTyrosine kinase inhibitors (TKI) are increasingly used as oral targeted therapies in oncology, where advanced renal cell carcinoma…”
Get full text

4CPS-077 Detection and communication of concomitant use of capecitabine and proton pump inhibitors by Guisado Gil, AB, Carrión Madroñal, IM, Sánchez Gómez, E, Santos Rubio, MD

“…Background and importanceRecent data suggest that the concurrent use of proton pump inhibitors (PPI) may reduce the efficacy of capecitabine by decreasing its…”
Get full text

5PSQ-005 Analysis of the adequacy of vitamin D prescriptions by Carrión Madroñal, IM, Martín Fernández, N, Arco Prados, Y, Grutzmancher Saiz, S, Santos Rubio, MD

“…Background and importanceIn recent years, a considerable increase in vitamin D determinations and supplementation has been observed, although there is…”
Get full text

5PSQ-037 Docetaxel induced neutropenic enterocolitis: a case report by Guisado Gil, AB, Carrión Madroñal, IM, Garrido Martínez, MT, Santos Rubio, MD

“…Background and importanceDocetaxel is an antineoplastic drug indicated for the treatment of several types of cancers, such as non-small cell lung cancer and…”
Get full text

4CPS-030 Analysis of adaptation to a protocol of use of the PCSK9 inhibitors by Yáñez Feria, D, Selvi Sabater, P, Pelaez Bejarano, A, Montero Pérez, O, Santos Rubio, MD

“…BackgroundThe aim of the Hospital Medicine and Therapeutics Committees (HMTC) is to promote the rational use of drugs through therapeutic improvement in terms…”
Get full text

1ISG-002 Budgetary impact of alirocumab repackaging in a third-level hospital by Báez, N, Romero Lara, C, Santos Rubio, MD, Muñoz Burgos, M, Rodriguez Ramallo, H

“…BackgroundHypercholesterolaemia is a common and growing health problem, above all in developed countries, which can cause serious consequences in patients who…”
Get full text

Failure mode effect analysis applied to preparation of intravenous cytostatics by Santos-Rubio, M D, Marín-Gil, R, Muñoz-de la Corte, R, Velázquez-López, M D, Gil-Navarro, M V, Bautista-Paloma, F J

“…To proactively identify risks in the preparation of intravenous cytostatic drugs, and to prioritise and establish measures to improve safety procedures…”
Get full text

4CPS-120 Erlotinib in non-small-cell lung cancer without epidermal growth factor receptor activating mutations by Yáñez Feria, D, Carrion Madroñal, IM, Garrido Martinez, MT, Montero Pérez, O, Santos Rubio, MD

“…BackgroundErlotinib is indicated in patients without epidermal growth factor receptor (EGFR)-activating mutations who have had at least one previous…”
Get full text

PKP-035 Factors correlated to high dose methotrexate severe intoxication: Nausea and vomiting by Ruiz, L Poyatos, Rubio, MD Santos, Guzman, MD Toscano, Alonso, E Montecatine, Bueno, C Villanueva, Garcia-Avello, A

“…BackgroundSevere intoxication with high dose methotrexate is life threatening, and hence determining contributing factors can help early rescue.PurposeTo…”
Get full text

GM-007 Satisfaction of health professionals on services provided by the clinic pharmacy management unit by Bueno, C Villanueva, Rubio, MD Santos, Guzman, MD Toscano, Turrion, J Martinez, Fernandez-Cueto, A Garcia-Avello, Torres, MI Sierra, Ruiz, LL Poyatos, Alonso, E Montecatine

“…BackgroundSurveys of satisfaction are an important tool to learn the strengths and weaknesses of the service and to assess influential factors to improve the…”
Get full text

Los sistemas de alertas como método de detección de errores de medicación by Santos-Rubio, M.D, Cotrina-Luque, J, Marín-Gil, R, Bautista-Paloma, F.J

Get full text

Stability of tirofiban hydrochloride in 0.9% sodium chloride injection for 30 days by GARABITO, Maria J, JIMENEZ, Luis, BAUTISTA, F. Javier, SANTOS-RUBIO, M. Dolores, PEREZ-RODRIGO, Iciar

Get full text

4CPS-131 Social function of the telepharmacy: a socioeconomic analysis by Domínguez Senín, L, Domínguez Berraquero, G, Rodriguez Jorge, M, Santos-Rubio, MD

“…Background and Importance remote medication delivery systems (telepharmacy) are increasingly used by hospitals nowadays. In our hospital an inclusion and…”
Get full text

5PSQ-026 Medication-related osteonecrosis of the jaws and CDK4/6 inhibitors by Domínguez Senín, L, Morales Pancorbo, D, Rodríguez Garcés, MY, Rodriguez Jorge, M, Santos-Rubio, MD, Bayo Calero, J

“…Background and ImportanceMedication-related osteonecrosis of the jaw (MRONJ) is a relatively uncommon but serious complication of osteoclast inhibitors therapy…”
Get full text

5PSQ-116 Persistence of inhibitors of interleukin-23 (anti-IL-23) for the treatment of moderate-to-severe psoriasis (msPs) in the routine clinical practice conditions by Domínguez Senín, L, Camacho Parreño, S, Sánchez Gómez, E, Rodriguez Jorge, M, Santos-Rubio, MD

“…Background and ImportanceAnti-IL-23 have emerged as safe and effective options for the treatment of msPs.Aim and ObjectivesWe aimed to evaluate the persistence…”
Get full text

5PSQ-157 Impact of anticholinergic burden, quantified by anticholinergic risk scales, on cognitive and functional status and falls in patients with multimorbidity: a preliminary study by Tristancho-Pérez, A, Belda Rustarazo, S, López-Malo, MD, Santos-Rubio, MD, Galván-Banqueri, M, Sánchez Fidalgo, S

“…BackgroundTaking multiple drugs with anticholinergic risk (AR) can adversely impact cognition and function. There are scales that rank the anticholinergic…”
Get full text

Assessment of safety practices for medication-use systems in Spanish hospitals (2007) by Otero López, M J, Martín Muñoz, M R, Castaño Rodríguez, B, Palomo Cobos, L, Cajaraville Ordoñana, G, Codina Jané, C, Martínez Cutillas, J, Pérez Encinas, M, Salvador Garrido, P, Santos Rubio, M D

“…To examine the current status of safety practices for medication-use systems in Spanish hospitals and to identify major areas of risk. Those hospitals that…”
Get more information

Work of a multidisciplinary team in the control of the prescription of ertapenem by Gil-Navarro, M V, Muñoz-Corte, R, Herrero Romero, M, Santos Rubio, M D, Cordero Matía, E, Bautista Paloma, J

“…To determine the effectiveness of the intervention of a multidiscipline antimicrobial control group in the correct prescription of Ertapenem. A four-month…”
Get full text